The Effect of Fluid Management by Pleth Variability Index on Acute Kidney Injury in Obese Patients
NCT ID: NCT03408834
Last Updated: 2018-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
29 participants
INTERVENTIONAL
2016-01-02
2017-10-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Intravenous Fluids on Perfusion Index and Pleth Variability Index
NCT03048162
Accuracy of the Pleth Variability Index to Predict Fluid Responsiveness in Liver Transplantation
NCT01792011
Comparison of PVI-guided Fluid Management With Traditional Fluid Management in Colorectal Surgery
NCT03339895
the Effects of Perioperative Goal Directed and Conventional Fluid Management on the IVC Collapsibility Index
NCT05154435
Internal Jugular Vein Distensibility and Pleth Variability Index(PVI) for Evaluating Fluid Responsiveness
NCT03673475
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients undergoing elective laparoscopic colorectal surgery, 18 to 75 years old, planned surgery duration longer than 2 hours, were included in this study. Patients were divided into 2 groups with respect to their fluid resuscitation, Group 1: goal directed fluid therapy via PVI monitoring Group 2: conventional fluid resuscitation. Blood samples were drawn from both groups for NGAL measurement before CO2 insufflation (T0), and at 6th(T1) and 12th(T2) hours after CO2 insufflation. At the end of the surgery, sugammadex was given to all patients for reversal of muscular blockade.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pulse variability index
fluid management performed by pulse variability index
pulse variability index
fluid management with pulse variability index or conventional
conventional fluid management
fluid management performed by conventional fluid management
pulse variability index
fluid management with pulse variability index or conventional
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pulse variability index
fluid management with pulse variability index or conventional
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* obese patient
Exclusion Criteria
* major comorbidity
* renal failure
* diabetes mellitus
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
CIGDEM YILDIRIM GUCLU
Associated professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
CIGDEM YILDIRIMGUCLU
Role: STUDY_CHAIR
Ankara University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-823-16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.